Joan Walker to Topoisomerase I Inhibitors
This is a "connection" page, showing publications Joan Walker has written about Topoisomerase I Inhibitors.
Connection Strength
0.093
-
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q). Gynecol Oncol. 2011 Mar; 120(3):454-8.
Score: 0.093